基于中医传承辅助平台探讨中医治疗特发性膜性肾病用药规律
Exploration of Medication Rules in Traditional Chinese Medicine for Idiopathic Membranous Nephropathy Based on the Traditional Chinese Medicine Inheritance Support Platform
DOI: 10.12677/tcm.2026.1510565, PDF,   
作者: 王雅宁, 唐 鹤:黑龙江省中医药科学院研究生院,黑龙江 哈尔滨;王铁良*:黑龙江省中医医院肾病科,黑龙江 哈尔滨
关键词: 特发性膜性肾病;中医传承辅助平台;数据挖掘;中医学;用药规律;Idiopathic Membranous Nephropathy; Traditional Chinese Medicine Inheritance Support Platform; Data Mining; Traditional Chinese Medicine; Medication Rules
摘要: 目的:基于中医传承辅助平台V2.5版,分析中国知网(CNKI)中当代中医药治疗特发性膜性肾病组方规律。方法:通过收集CNKI中采用中医方剂治疗特发性膜性肾病的相关文献,运用中医传承辅助平台V2.5软件建立数据库,分析并总结特发性膜性肾病方药特点。结果:CNKI中治疗特发性膜性肾病方剂共78首,包含中药347种,分析出黄芪、茯苓、当归使用频率较高,药性以平、温、寒性药为主;五味以甘、苦、辛、酸味为主;主要归脾、肝、肾;得常用药对及配伍规律为黄芪–茯苓、黄芪–当归、党参–黄芪为常用药物组,演化得到新处方5首。结论:通过中医组方以甘温健脾、固肾摄精为主。可为临床治疗和后续研究提供参考。
Abstract: Objective: Based on the Traditional Chinese Medicine Inheritance Support Platform (V2.5), this study analyzes the formulation rules of contemporary traditional Chinese medicine for idiopathic membranous nephropathy in the China National Knowledge Infrastructure (CNKI). Methods: Relevant literature on traditional Chinese herbal prescriptions for idiopathic membranous nephropathy was collected from CNKI. A database was established using the Traditional Chinese Medicine Inheritance Support Platform (V2.5) to analyze and summarize the characteristics of herbal prescriptions for idiopathic membranous nephropathy. Results: A total of 78 prescriptions for idiopathic membranous nephropathy were collected from CNKI, involving 347 Chinese medicinal herbs. Astragali Radix, Poria and Angelicae Sinensis Radix were used relatively frequently. The medicinal properties were mainly neutral, warm and cold. The dominant flavors were sweet, bitter, pungent and sour. The herbs mainly act on the spleen, liver and kidney meridians. The frequently used herb pairs and compatibility rules included Astragali Radix-Poria, Astragali Radix-Angelicae Sinensis Radix, and Codonopsis Radix-Astragali Radix. Five new prescriptions were obtained through evolution. Conclusion: The TCM prescriptions are mainly characterized by invigorating the spleen with sweet-warm herbs, consolidating the kidney and securing essence. The findings can provide references for clinical treatment and further research.
文章引用:王雅宁, 唐鹤, 王铁良. 基于中医传承辅助平台探讨中医治疗特发性膜性肾病用药规律[J]. 中医学, 2026, 15(10): 352-361. https://doi.org/10.12677/tcm.2026.1510565

参考文献

[1] 刘英杰, 张启东, 郭维康, 等. 北京地区单中心2008-2018年特发性膜性肾病流行病学变迁[J]. 临床和实验医学杂志, 2019, 18(2): 181-183.
[2] Bharati, J., Waguespack, D.R. and Beck, L.H. (2024) Membranous Nephropathy: Updates on Management. Advances in Kidney Disease and Health, 31, 299-308.
https://doi.org/10.1053/j.akdh.2024.04.004
[3] 刘宝利, 钟逸斐, 刘伟敬, 等. 中医药临床优势病种探讨——膜性肾病[J]. 中国实验方剂学杂志, 2021, 27(16): 185-190.
[4] 国家药典委员会. 中华人民共和国药典2020版[M]. 北京: 中国医药科技出版社, 2020.
[5] 李琦, 任冉, 李宗涛, 等. 赵玉庸治疗膜性肾病之经验[J]. 江苏中医药, 2021, 53(8): 20-22.
[6] 胡映雪, 朱彩凤. 朱彩凤运用益气行瘀消癥法治疗特发性膜性肾病经验[J]. 浙江中西医结合杂志, 2021, 31(12): 1087-1089.
[7] 李双良. 特发性膜性肾病的免疫抑制剂治疗研究进展[J]. 中国实用乡村医生杂志, 2023, 30(10): 23-25.
[8] 史洲, 李建英. 特发性膜性肾病中医药研究进展[J]. 中国中医药现代远程教育, 2023, 21(18): 202-205.
[9] 曹博宁, 王耀献. 论黄芪在膜性肾病治疗中的应用[J]. 中医杂志, 2024, 65(16): 1725-1729+1740.
[10] 柯曼, 汤水福. 汤水福采用益气升提法治疗肾性蛋白尿经验[J]. 广州中医药大学学报, 2024, 41(3): 764-768.
[11] 庞欣欣, 彭紫凝, 邢玉凤, 等. 基于网络药理学研究黄芪治疗膜性肾病的作用机制[J]. 中国合理用药探索, 2021, 18(7): 88-95.
[12] 郑健. 基于药性理论探讨中医药辨治无瘤康复阶段肺癌的组方用药规律[J]. 中国现代医生, 2024, 62(26): 67-70+75.
[13] 张淼, 霍海如, 王朋倩, 等. 辛味药性理论溯源与现代研究评述[J]. 中草药, 2018, 49(3): 505-511.
[14] 李学林, 崔瑛, 曹俊岭. 实用临床中药学(中药饮片部分) [M]. 北京: 人民卫生出版社, 2013: 16-27.
[15] 张尧, 高飞, 檀淼, 等. 丹参多酚酸盐通过AMPK/Sirt1/PGC-1α信号通路诱导膜性肾病大鼠足细胞自噬的机制[J]. 中国实验方剂学杂志, 2023, 29(8): 203-213.
[16] 李鑫, 雷根平, 冯喆, 等. 基于足细胞损伤探讨中医药干预膜性肾病研究进展[J]. 中国实验方剂学杂志, 2023, 29(12): 257-264.